WILMINGTON, Del.--(BUSINESS WIRE)--Nov. 17, 2022--
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of November and December:
Evercore ISI 5th Annual HealthCONx Conference (Virtual) on Tuesday, November 29, 2022 at 12:35 pm (EST)
Bank of America Securities 2022 Biotech SMID Cap Conference on Wednesday, December 7, 2022 at 8:35 am (EST) in Boston
The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221117005001/en/
+1 302 498 6171
+1 302 274 4773